HK Stock Market Move | CUTIA-B(02487) rose by more than 9%, hitting a new high in nearly half a year. It will welcome three heavyweight pipelines this year. CICC is optimistic about their long-term growth potential.

CUTIA-B (02487) rose more than 9%, reaching a high of 8.17 Hong Kong dollars, the highest since November last year. As of the time of writing, it has risen by 9.12%, at 8.14 Hong Kong dollars, with a trading volume of 18.4459 million Hong Kong dollars. On the news front, Founder's previous research report pointed out that the company is a newcomer in the rapidly growing market for the treatment and care of skin diseases, with a commercialization-oriented approach and innovation as the core driver. The commercialization breakthrough of the Minodere series products and the efficacy skincare brand Oma are leading the way, and the company is rapidly shifting towards multi-matrix iterations, with important milestones expected in the next 25 years. Zhongjin stated that the hair and skin care product line is quickly gaining traction, with user stickiness continuously increasing. The intensive landing of future pipelines is expected to contribute to performance growth, and the company is optimistic about the long-term growth space towards becoming a skin management platform.